Omeros Corp (OMER)
3.21
-0.13
(-3.89%)
USD |
NASDAQ |
Apr 18, 16:00
3.22
+0.01
(+0.31%)
After-Hours: 20:00
Omeros Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2020 | 98.46% |
June 30, 2020 | 98.91% |
March 31, 2020 | 98.87% |
December 31, 2019 | 99.41% |
September 30, 2019 | 99.07% |
June 30, 2019 | 99.79% |
March 31, 2019 | 99.40% |
December 31, 2018 | 99.29% |
September 30, 2018 | 99.22% |
June 30, 2018 | 92.99% |
March 31, 2018 | 87.22% |
December 31, 2017 | 96.62% |
Date | Value |
---|---|
September 30, 2017 | 99.15% |
June 30, 2017 | 99.08% |
March 31, 2017 | 97.79% |
December 31, 2016 | 97.06% |
September 30, 2016 | 96.65% |
June 30, 2016 | 96.73% |
March 31, 2016 | 95.59% |
December 31, 2015 | 93.75% |
September 30, 2015 | 92.39% |
June 30, 2015 | 88.55% |
March 31, 2015 | 97.16% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
98.46%
Minimum
Sep 2020
99.79%
Maximum
Jun 2019
99.09%
Average
98.99%
Median
Gross Profit Margin (Quarterly) Benchmarks
Aspira Womens Health Inc | 57.23% |
Ardelyx Inc | 85.23% |
Panbela Therapeutics Inc | -- |
Ensysce Biosciences Inc | -- |
MAIA Biotechnology Inc | -- |